{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:04:06Z","timestamp":1784610246563,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The increasing use of bronchoalveolar lavage fluid (BALF) metagenomic next-generation sequencing (mNGS) has substantially improved the detection of\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      species in patients with suspected pulmonary infections. However, positive mNGS results frequently present a clinical dilemma because\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      may represent invasive pulmonary aspergillosis (IPA), airway colonization, or transient fungal detection. The clinical value of quantitative fungal burden assessment remains insufficiently defined, particularly regarding risk stratification among untreated patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective real-world cohort study including 114 hospitalized patients with BALF mNGS-positive\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      detected between April 2024 and November 2025. Patients were classified according to clinical IPA diagnosis, antifungal treatment status, and occurrence of respiratory deterioration during a 3-month follow-up period. Quantitative fungal burden was expressed as reads per ten million (RPTM). Receiver operating characteristic (ROC) analysis, logistic regression, integrated discrimination improvement (IDI), and category-free net reclassification improvement (NRI) were used to evaluate diagnostic and prognostic performance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 114 patients, 31 met clinical diagnostic criteria for IPA and 83 were classified as non-IPA.\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      burden was significantly higher in IPA patients than in non-IPA patients (logarithmic scale median RPTM 2.46 vs. 0.30, P &amp;lt; 0.001). ROC analysis identified an exploratory cohort-derived diagnostic threshold of 75 RPTM for IPA discrimination (AUC\u00a0=\u00a00.853, 95% CI 0.745\u20130.960). Among 77 patients who did not receive antifungal therapy, 31 experienced respiratory deterioration during follow-up. Higher RPTM values were independently associated with deterioration (adjusted OR\u00a0=\u00a05.27, 95% CI 1.78\u201317.06, P\u00a0=\u00a00.001). An exploratory RPTM threshold of 2.5 showed modest discriminatory ability for subsequent respiratory deterioration, with an AUC of 0.682. Incorporation of quantitative fungal burden significantly improved discrimination and reclassification performance beyond conventional clinical variables. In contrast, baseline RPTM showed no significant association with respiratory deterioration among patients receiving antifungal therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Quantitative interpretation of\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      -positive BALF mNGS results may provide additional information beyond simple pathogen detection. Two exploratory cohort-derived thresholds were identified: a higher threshold associated with clinical IPA adjudication and a lower threshold associated with subsequent respiratory deterioration among untreated patients. These findings are hypothesis-generating and require external validation before clinical application. RPTM should be interpreted as an adjunctive marker within the overall clinical context rather than as a standalone diagnostic or prognostic threshold.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1897649","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:04Z","timestamp":1784607604000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond detection: quantitative interpretation of Aspergillus-positive bronchoalveolar lavage fluid metagenomic next-generation sequencing for diagnostic stratification and prediction of respiratory deterioration"],"prefix":"10.3389","volume":"16","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Lei","sequence":"additional","affiliation":[{"name":"School of Public Health, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyao","family":"Cui","sequence":"additional","affiliation":[{"name":"School of Public Health, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixi","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Public Health, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.925982","article-title":"Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study","volume":"12","author":"Bao","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/459405","article-title":"Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome","volume":"2013","author":"Barton","year":"2013","journal-title":"Scientifica."},{"key":"B3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur. Respir. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1093\/mmy\/myy076","article-title":"Pathophysiological aspects of Aspergillus colonization in disease","volume":"57","author":"Gago","year":"2019","journal-title":"Med. Mycol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/ffunb.2026.1751760","article-title":"Metagenomic next-generation sequencing unveils invasive aspergillosis masquerading as miliary tuberculosis in a neutropenic leukemia patient: a case report","volume":"7","author":"Ji","year":"2026","journal-title":"Front. Fungal Biol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1223576","article-title":"Diagnostic efficacy of metagenomic next generation sequencing in bronchoalveolar lavage fluid for proven invasive pulmonary aspergillosis","volume":"13","author":"Jia","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1345706","article-title":"Clinical performance of metagenomic next-generation sequencing for diagnosis of pulmonary Aspergillus infection and colonization","volume":"14","author":"Jiang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09059180.00001011","article-title":"Pulmonary aspergillosis: a clinical review","volume":"20","author":"Kousha","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1739837","article-title":"Integrative diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients using BALF-tNGS-derived Aspergillus load and host risk factors: a multicenter study","volume":"16","author":"Liu","year":"2026","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2023.116135","article-title":"Comparison of different criteria of metagenomic next-generation sequencing for the diagnosis of invasive pulmonary aspergillosis in critically ill patients","volume":"108","author":"Liu","year":"2024","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12879-025-10560-y","article-title":"Invasive aspergillosis in critically ill patients with diabetes mellitus: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1397733","article-title":"Clinical utility of metagenomic next-generation sequencing in the diagnosis of invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease patients in the intensive care unit","volume":"14","author":"Niu","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108206","article-title":"Pulmonary aspergillosis: epidemiology and unresolved diagnostic challenges - insights from a two-year retrospective cohort study in Marseille","volume":"245","author":"Pham","year":"2025","journal-title":"Respir. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jof10040251","article-title":"Interplay of cytokines and chemokines in aspergillosis","volume":"10","author":"Shankar","year":"2024","journal-title":"J. Fungi (Basel)."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03435-22","article-title":"Validity of Platelia Aspergillus IgG and Aspergillus precipitin test to distinguish pulmonary aspergillosis from colonization","volume":"11","author":"Shinfuku","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037845","article-title":"Clinical application of metagenomic next-generation sequencing for the diagnosis of suspected infection in adults: a cross-sectional study","volume":"103","author":"Sun","year":"2024","journal-title":"Med. (Baltimore)."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit. Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/jof8050480","article-title":"Clinical Aspergillus signatures in COPD and bronchiectasis","volume":"8","author":"Tiew","year":"2022","journal-title":"J. Fungi"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s00134-007-0791-z","article-title":"Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients","volume":"33","author":"Trof","year":"2007","journal-title":"Intensive Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc4823","article-title":"Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients","volume":"10","author":"Vandewoude","year":"2006","journal-title":"Crit. Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00607-25","article-title":"Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: a multicenter cohort study","volume":"13","author":"Wang","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000547550","article-title":"The triad of pathogenesis in allergic bronchopulmonary aspergillosis: interactions among Aspergillus fumigatus, epithelium, and immunity","volume":"187","author":"Wang","year":"2026","journal-title":"Int. Arch. Allergy Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.2147\/idr.s333818","article-title":"Metagenomic next-generation sequencing for pulmonary fungal infection diagnosis: lung biopsy versus bronchoalveolar lavage fluid","volume":"14","author":"Yang","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"B29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/myc.13557","article-title":"Evaluation of metagenomic next-generation sequencing diagnosis for invasive pulmonary aspergillosis in immunocompromised and immunocompetent patients","volume":"66","author":"Zhan","year":"2023","journal-title":"Mycoses."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1631960","article-title":"Clinical performance of metagenomic next-generation sequencing for distinction and diagnosis of Mucorales infection and colonization","volume":"15","author":"Zhou","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1271853","article-title":"Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients","volume":"13","author":"Zhu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043347","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS One"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1897649\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:05Z","timestamp":1784607605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1897649\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":32,"alternative-id":["10.3389\/fcimb.2026.1897649"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1897649","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1897649"}}